Osteoporosis and Bone Health

Bone Is Living Tissue — and Living Tissue Responds

Osteoporosis is so normalized in aging Western medicine that many patients are surprised to learn it has upstream drivers beyond age and genetics — drivers that can be evaluated, influenced, and in some cases substantially reversed. Bone density is not a static measurement; it is the net outcome of a continuous remodeling process that is exquisitely sensitive to hormonal signals, nutritional status, mechanical loading, and inflammation.

Standard care — bisphosphonates, denosumab, teriparatide — addresses the remodeling imbalance pharmacologically. These drugs work. They also come with concerns that limit their long-term use: bisphosphonates accumulate in bone indefinitely, carry a small but real risk of atypical femur fracture with prolonged use, and suppress the remodeling cycle so completely that old bone cannot be replaced. They are appropriate for high-fracture-risk patients. They are often prescribed reflexively for patients whose bone density might respond meaningfully to terrain-based intervention first.

That terrain includes: estrogen and testosterone status, thyroid function, parathyroid function, vitamin D and calcium metabolism, gut absorption capacity, cortisol (chronic cortisol elevation is one of the most potent drivers of bone loss), and the mechanical loading signals that tell the bone to maintain its density. None of these are addressed by bisphosphonates. All of them are addressable.

What's Actually Happening in Osteoporosis

Bone is continuously remodeled by two opposing cell types: osteoclasts, which break down old bone, and osteoblasts, which build new bone. The balance between them determines bone mineral density (BMD). In healthy adults, formation and resorption are roughly equal. Osteoporosis occurs when resorption outpaces formation — most commonly after menopause, when the protective effects of estrogen on osteoclast suppression are withdrawn.

The most clinically significant sites are the lumbar spine, femoral neck, and distal radius — all locations where osteoporotic fractures cause disproportionate morbidity. Hip fractures in particular carry 20–30% one-year mortality in older adults and are a sentinel event for functional decline.

Bone density as measured by DEXA provides a T-score that classifies bone as normal (above -1), osteopenic (-1 to -2.5), or osteoporotic (below -2.5). But T-score alone doesn't determine fracture risk — bone quality, fall risk, functional strength, and the rate of bone loss over time all matter and often get less attention than the single number.

Contributing factors beyond menopause include: male hypogonadism, prolonged corticosteroid use, untreated hyperthyroidism, malabsorption disorders (celiac, IBD), eating disorders, excessive alcohol, smoking, inadequate physical activity, low body weight, and medications including proton pump inhibitors and SSRIs. Vitamin D deficiency is nearly universal in osteoporotic patients in Seattle — the geographic latitude makes sunlight-dependent synthesis insufficient for most of the year.

The TCM View of Bone Health

In Chinese medicine, the Kidney governs bones and marrow. Kidney Jing (constitutional essence) is the deep biological capital from which bones, marrow, and reproductive tissue are built. As Jing naturally declines with age, the bones lose their density and resilience — this is the Chinese medicine description of osteoporosis, written centuries before DEXA scans existed.

Kidney Yang Deficiency. Cold limbs, frequent urination, low back weakness, fatigue, and fear of cold alongside bone fragility. The warming, activating aspect of Kidney is depleted. Treatment: warming herbs, moxibustion, Yang-tonifying formulas.

Kidney Yin Deficiency. Hot flashes, night sweats, dry mouth, dizziness, and restless heat alongside bone loss — the classic postmenopausal pattern. The cooling, nourishing aspect is depleted. Treatment: Yin-tonifying and marrow-nourishing herbs, including Rehmannia and Cornus-based formulas.

Spleen Deficiency. The Spleen governs transportation and transformation of nutrients. Spleen deficiency impairs the digestion and absorption of the bone-building materials — calcium, phosphorus, protein — regardless of how much the patient consumes. Symptoms include digestive weakness, easy bruising, and fatigue. Treatment: Spleen Qi tonification, digestive support.

Blood Stasis. Fixed bone pain, particularly after fracture or in areas of chronic ischemia. Treatment: blood-moving herbs to improve periosteal circulation and support fracture healing.

How We Support Bone Health at GoodMedizen

Acupuncture for bone density and pain. Systematic reviews confirm acupuncture improves bone mineral density in postmenopausal osteoporosis. A 2022 meta-analysis found acupuncture has therapeutic effects on BMD enhancement. Combined acupuncture and herbal medicine has outperformed calcium plus calcitonin in controlled trials, yielding greater BMD improvements and more significant pain reduction. Points targeting the Kidney back-shu (BL23), Spleen back-shu (BL20), and bone-point Dazhu (BL11), combined with ST36 and distal Kidney meridian points, are central to the treatment approach.

Moxibustion. Thermal stimulation at Kidney and spinal back-shu points warms Yang, tonifies Kidney, and has been shown in clinical trials to improve BMD and reduce inflammatory cytokines that drive bone resorption. Moxibustion is particularly indicated in cold-pattern Kidney Yang Deficiency presentations.

Chinese herbal medicine. Formulas like Liu Wei Di Huang Wan (Kidney Yin), You Gui Wan (Kidney Yang), and the herb Dipsacus (Xu Duan, "joins broken bones") are the cornerstone of the herbal approach. Research has characterized their mechanisms: regulation of osteoblast-osteoclast balance, promotion of osteogenesis via MAPK1 and miR-574 pathways, and calcitonin regulation. We prescribe individually to your pattern and stage.

Functional medicine assessment. We evaluate: comprehensive thyroid panel (including free T3, which directly affects bone resorption), sex hormones (estrogen, testosterone, DHEA), vitamin D (25-OH and 1,25-OH), parathyroid hormone, calcium-phosphorus metabolism, cortisol, and gut absorption capacity. Every reversible driver of bone loss that standard care misses gets addressed.

Targeted nutraceuticals. Vitamin D3 with K2 (K2 directs calcium to bone rather than arteries), magnesium glycinate, calcium (ideally from food, or as supplement only when needed and in divided doses to improve absorption), silicon, strontium, and boron — each with specific roles in the bone matrix. We don't scatter supplements; we test and target.

Pain management for vertebral fractures and hip pain. Acupuncture and Point Injection Therapy for vertebral compression fracture pain, hip pain, and the diffuse aching of deficient bone provide meaningful relief without the long-term risks of analgesics or the bone-further-weakening effects of chronic steroid use.

When to Consider Us

• You've been diagnosed with osteopenia or osteoporosis and want to address upstream drivers before or alongside medication
• You are postmenopausal and want to protect your bones naturally with integrated hormonal and nutritional support
• You are on bisphosphonates and want to optimize the terrain they're acting on
• You've had a fracture and want to support healing and prevent future fractures
• You have bone pain — vertebral, hip, or otherwise — and want effective pain management
• Vitamin D deficiency (nearly universal in Seattle's latitude) and you want a comprehensive evaluation of your bone metabolic status

Selected References

• Liu, B. et al. (2022). Acupuncture for postmenopausal osteoporosis: a systematic review and network meta-analysis. Front. Endocrinol.
• Zheng, X. et al. (2019). Chinese herbal medicine combined with acupuncture vs. calcium plus calcitonin for postmenopausal osteoporosis. J Tradit Chin Med, 39(4).
• Wang, H. et al. (2021). Liu Wei Di Huang Wan regulates osteoporosis via miR-574 and MAPK1 pathways. J Ethnopharmacol, 265, 113320.